Ventura, CA, United States of America

Thomas M Dillon

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 7.5

ph-index = 2

Forward Citations = 60(Granted Patents)


Company Filing History:


Years Active: 2008-2011

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Thomas M Dillon: Innovator in Antibody Production and Analysis

Introduction

Thomas M Dillon is a notable inventor based in Ventura, CA (US), recognized for his contributions to the field of biotechnology. He holds 2 patents that focus on innovative methods for the production and analysis of antibodies, which are crucial in various medical applications.

Latest Patents

Dillon's latest patents include "Methods for refolding of recombinant antibodies," which is directed towards enhancing the enrichment and recovery of preferred forms of IgG proteins. This invention involves subjecting preparations of recombinant IgG proteins to a reduction/oxidation coupling reagent, optionally combined with a chaotropic agent. Another significant patent is the "LC/MS method of analyzing high molecular weight proteins," which presents a novel reversed-phase LC/MS method for analyzing high molecular weight proteins, including antibodies.

Career Highlights

Throughout his career, Dillon has made significant strides in the biotechnology sector, particularly in the development of methods that improve the efficiency and effectiveness of antibody production and analysis. His work has implications for therapeutic applications and research in immunology.

Collaborations

Dillon has collaborated with esteemed colleagues such as Douglas Rehder and Pavel V Bondarenko, contributing to advancements in their shared field of expertise.

Conclusion

Thomas M Dillon's innovative work in antibody production and analysis underscores his importance in the biotechnology industry. His patents reflect a commitment to enhancing scientific understanding and practical applications in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…